Leadership
Dr. Marvin J. Fritzler
Dr. Marvin J. Fritzler, the founder of MitogenDx, has served as its Director for over 50 years. Dr. Fritzler is also Professor Emertius at the University of Calgary, Cumming School of Medicine. He received his PhD in Cell Biology at the University of Calgary, Dr. Fritzler continued with postdoctoral research in Autoimmunity at the Scripps Clinic and Research Institute in La Jolla, CA and at the University of Colorado in Denver. His areas of expertise include autoimmune diseases, cell and molecular biology of autoantigens, and laboratory diagnostics. Under Dr. Fritzler’s leadership and driven by his passion for precision and companion health, MitogenDx has gained international recognition as a leader in diagnostic medicine.
Education
- Post-Doctoral: Autoimmunity (Scripps Clinic and Research Institute, La Jolla CA; University of Colorado, Denver CO)
- PhD: Cell Biology (University of Calgary)
- MD: Medicine (University of Calgary)
- BSc: Zoology/Biology (University of Alberta)
Areas of Expertise
- Autoimmune Diseases
- Environmental Medicine
- Cell and Molecular Biology of Autoantigens
- Precision Medicine
- Laboratory Diagnostics
- Strategy & Policy: Science, Research, Technology, Innovation
Key Member of Team Research
- Canadian Scleroderma Research Group
- Canadian Inflammatory Myopathy Study (CIMS)
- UCAN-CANDU-CANCure: Canada–Netherlands Study of Juvenile Arthritis
- Tri-Nation (Canada, USA, Australia) Scleroderma Research Group
- LEAPPS: Longitudinal Examination of ANA Prevalence, Predictors and Performance in SLE
- International Consensus on Antinuclear Antibody Patterns (ICAP)
Dr. May Y. Choi
Dr. May Choi is the Associate Director of MitogenDx, bringing extensive expertise in autoimmune diseases and innovative diagnostics. She completed her MD at the University of Alberta and training in Internal Medicine and Rheumatology at the University of Calgary. Dr. Choi holds a Master of Public Health in Epidemiology from Harvard University and completed a clinical and research lupus fellowship at Brigham and Women’s Hospital, Harvard Medical School. Her areas of expertise include systemic lupus erythematosus, biomarker discovery, precision medicine, and the application of artificial intelligence in laboratory diagnostics. Dr. Choi’s leadership at MitogenDx supports the company’s mission to deliver advanced autoimmune diagnostic services on local, national, and international scales.
Education
- Lupus Fellowship: Clinical and Research Lupus Fellowship (Brigham and Women’s Hospital, Harvard Medical School)
- Graduate: Master of Public Health, Epidemiology (Harvard University)
- MD: Medicine (University of Alberta)
- BHSc: Biomedical Sciences, Honours (University of Calgary)
Areas of Expertise
- Autoimmune Diseases
- Lupus (Systemic Lupus Erythematosus)
- Biomarker Discovery and Autoantibody Profiling
- Precision Medicine
- Artificial Intelligence & Machine Learning in Diagnostics
- Epidemiology & Public Health
- Translational Research and Biobanking
- Laboratory Diagnostics
Key Member of Team Research
- Canadian Scleroderma Research Group (CSRG)
- Lupus Study Group
- Arthritis Research Canada
- CanRIO: The Canadian Research Group of Rheumatology in Immuno-Oncology
- CaNIOS: The Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus